{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:59:59Z","timestamp":1792450799469,"version":"4.5.0"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T00:00:00Z","timestamp":1613520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Idiopathic pulmonary fibrosis (IPF) is a progressively and ultimately fatal lung disease. Previously it has been shown that intratracheal administration of alveolar epithelial type II cells (AE2C) in the animal model of bleomycin-induced pulmonary fibrosis is able to reverse fibrosis and restore surfactant protein levels. However, to date, it has not been evaluated whether these changes involve any improvement in alveolar dynamics. Consequently, the aim of the present work was to study lung physiology after AE2C transplantation at different time points during the development of injury and fibrosis. Lung fibrosis was induced by intratracheal instillation of bleomycin (4U\/kg) in rat lungs. The animals were transplanted with AE2C (2.5 \u00d7 10<jats:sup>6<\/jats:sup> cells\/animal) 3 or 7 days after bleomycin instillation. Assessments were done at day 7 and 14 after the induction of fibrosis to plot time dependent changes in lung physiology and mechanics. To assess the pressures and rates at which closed alveoli reopens invasive pulmonary tests using a small-animal mechanical ventilator (Flexivent\u00ae, Scireq, Canada) including de-recruitability tests and forced oscillation technique as well as quasi-static pressure volume loops were performed. Afterwards lungs were fixed by vascular perfusion and subjected to design-based stereological evaluation at light and electron microscopy level. AE2C delivered during the lung injury phase (3 days) of the disease are only able to slightly recover the volume of AE2C and volume fraction of LB in AE2C. However, it did not show either positive effects regarding ventilated alveolar surface nor any increase of lung compliance. On the other hand, when AE2C are delivered at the beginning of the fibrotic phase (7 days after bleomycin instillation), an increased ventilated alveolar surface to control levels and reduced septal wall thickness can be observed. Moreover, transplanted animals showed better lung performance, with increased inspiratory capacity and compliance. In addition, a detailed analysis of surfactant active forms [mainly tubular myelin, lamellar body (LB)-like structures and multilamellar vesicles (MLV)], showed an effective recovery during the pro-fibrotic phase due to the healthy AE2C transplantation. In conclusion, AE2C transplantation during fibrogenic phases of the disease improves lung performance, structure and surfactant ultrastructure in bleomycin-induced lung fibrosis.<\/jats:p>","DOI":"10.3389\/fmed.2021.640020","type":"journal-article","created":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T20:59:53Z","timestamp":1613768393000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Improved Alveolar Dynamics and Structure After Alveolar Epithelial Type II Cell Transplantation in Bleomycin Induced Lung Fibrosis"],"prefix":"10.3389","volume":"8","author":[{"given":"Elena","family":"Lopez-Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Gay-Jordi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Ochs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Serrano-Mollar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"ATS\/ERS\/JRS\/ALAT committee on idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am J Respir Crit Care Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/S0140-6736(11)60405-4","article-title":"Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials","volume":"377","author":"Noble","year":"2011","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1056\/NEJMoa1103690","article-title":"Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis","volume":"365","author":"Richeldi","year":"2011","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1365-2184.2004.00302.x","article-title":"Pulmonary epithelial stem cells","volume":"37","author":"Bishop","year":"2004","journal-title":"Cell Prolif"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1378\/chest.94.6.1309","article-title":"Epithelial necrosis and alveolar collapse in the pathogenesis of usual interstitial pneumonia","volume":"94","author":"Myers","year":"1988","journal-title":"Chest"},{"key":"B6","doi-asserted-by":"publisher","first-page":"L1192","DOI":"10.1152\/ajplung.1998.275.6.L1192","article-title":"Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung","volume":"275","author":"Uhal","year":"1998","journal-title":"Am J Physiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1513\/pats.200601-003TK","article-title":"Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers","volume":"3","author":"Selman","year":"2006","journal-title":"Proc Am Thorac Soc"},{"key":"B8","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1034\/j.1399-3003.1999.14c14.x","article-title":"Surfactant abnormalities in idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and sarcoidosis","volume":"14","author":"G\u00fcnther","year":"1999","journal-title":"Eur Respir J"},{"key":"B9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000272061","article-title":"The closer we look the more we see? Quantitative microscopic analysis of the pulmonary surfactant system","volume":"25","author":"Ochs","year":"2010","journal-title":"Cell Physiol Biochem"},{"key":"B10","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1152\/physiol.00006.2010","article-title":"Pulmonary surfactant pathophysiology: current models and open questions","volume":"25","author":"Perez-Gil","year":"2010","journal-title":"Physiology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1152\/jappl.1979.47.5.1002","article-title":"Alterations of mechanical properties and morphology in excised rabbit lungs rinsed with a detergent","volume":"47","author":"Bachofen","year":"1979","journal-title":"J Appl Physiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1152\/japplphysiol.01105.2012","article-title":"Murine pulmonary acinar mechanics during quasi-static inflation using synchrotron refraction-enhanced computed tomography","volume":"115","author":"Sera","year":"2013","journal-title":"J Appl Physiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1152\/jappl.1970.28.5.596","article-title":"Stress distribution in lungs: a model of pulmonary elasticity","volume":"28","author":"Mead","year":"1970","journal-title":"J Appl Physiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1164\/rccm.201508-1638OC","article-title":"Stretch-induced activation of transforming growth factor-\u03b21 in pulmonary fibrosis","volume":"194","author":"Froese","year":"2016","journal-title":"Am J Resp Crit Care Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1097\/CCM.0b013e31822f09d7","article-title":"Mechanical stress induces lung fibrosis by epithelial-mesenchymal transition","volume":"40","author":"Cabrera-Ben\u00edtez","year":"2012","journal-title":"Crit Care Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1164\/rccm.200810-1615OC","article-title":"Targeted injury of type II alveolar epithelial cells induces pulmonary fibrosis","volume":"181","author":"Sisson","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1164\/ajrccm\/140.2.513","article-title":"Alveolitis and collapse in the pathogenesis of pulmonary fibrosis","volume":"140","author":"Burkhardt","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1164\/rccm.200610-1491OC","article-title":"Intratracheal transplantation of alveolar type II cells reverses bleomycin-induced lung fibrosis","volume":"176","author":"Serrano-Mollar","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.healun.2014.03.008","article-title":"Alveolar type II cell transplantation restores pulmonary surfactant protein levels in lung fibrosis","volume":"33","author":"Guillamat-Prats","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e33165","DOI":"10.1371\/journal.pone.0033165","article-title":"Human embryonic stem cells differentiated to lung lineage-specific cells ameliorate pulmonary fibrosis in a xenograft transplant mouse model","volume":"7","author":"Banerjee","year":"2012","journal-title":"PLoS ONE"},{"key":"B21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/SHK.0b013e318285f2e2","article-title":"Induced pluripotent stem cells mediate the release of interferon gamma-induced protein 10 and alleviate bleomycin induced lung inflammation and fibrosis","volume":"39","author":"How","year":"2013","journal-title":"Shock"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.3892\/mmr.2014.2981","article-title":"Conversion of bone marrow mesenchymal stem cells into type II alveolar epithelial cells reduces pulmonary fibrosis by decreasing oxidative stress in rats","volume":"11","author":"Huang","year":"2015","journal-title":"Mol Med Rep."},{"key":"B23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s13287-020-01726-3","article-title":"Induced pluripotent stem cell-derived lung alveolar epithelial type II cells reduce damage in bleomycin-induced lung fibrosis","volume":"11","author":"Alvarez-Palomo","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"B24","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3390\/medsci6030064","article-title":"Cell therapy in idiopathic pulmonary fibrosis\u2020","volume":"6","author":"Serrano-Mollar","year":"2018","journal-title":"Med Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.chest.2016.03.021","article-title":"Safety and tolerability of alveolar type II cell transplantation in idiopathic pulmonary fibrosis","volume":"150","author":"Serrano-Mollar","year":"2016","journal-title":"Chest"},{"key":"B26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/BF02714430","article-title":"Isolation, biochemical characterisation, and culture of lung type II cells of the rat","volume":"165","author":"Richards","year":"1987","journal-title":"Lung"},{"key":"B27","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1165\/rcmb.2018-0044OC","article-title":"Alveolar micromechanics in bleomycin-induced lung injury","volume":"59","author":"Knudsen","year":"2018","journal-title":"Am J Resp Cell Mol Biol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1164\/rccm.200809-1522ST","article-title":"An official research policy statement of the american thoracic society\/european respiratory society: standards for quantitative assessment of lung structure","volume":"181","author":"Hsia","year":"2010","journal-title":"Am J Resp Crit Care Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"L15","DOI":"10.1152\/ajplung.00429.2012","article-title":"Quantitative microscopy of the lung: a problem-based approach. Part 1: basic principles of lung stereology","volume":"305","author":"Ochs","year":"2013","journal-title":"Am J Physiol-Lung Cell Mol Physiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1165\/rcmb.2014-0078OC","article-title":"Alveolar derecruitment and collapse induration as crucial mechanisms in lung injury and fibrosis","volume":"52","author":"Lutz","year":"2015","journal-title":"Am J Resp Cell Mol Biol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1164\/ajrccm.160.2.9809060","article-title":"Ultrastructural alterations in intraalveolar surfactant subtypes after experimental ischemia and reperfusion","volume":"160","author":"Ochs","year":"1999","journal-title":"Am J Resp Crit Care Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.3390\/ijms21072269","article-title":"Alveolar epithelial type II cells as drivers of lung fibrosis in idiopathic pulmonary fibrosis","volume":"21","author":"Parimon","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B33","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/toxsci\/kfu177","article-title":"Altered surfactant homeostasis and alveolar epithelial cell stress in amiodarone-induced lung fibrosis","volume":"142","author":"Mahavadi","year":"2014","journal-title":"Tox Sci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1164\/rccm.200802-313OC","article-title":"Epithelial endoplasmic reticulum stress and apoptosis in sporadic idiopathic pulmonary fibrosis","volume":"178","author":"Korfei","year":"2008","journal-title":"Am J Resp Crit Care Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s00441-016-2520-9","article-title":"Lung surfactant metabolism: early in life, early in disease and target in cell therapy","volume":"367","author":"Lopez-Rodriguez","year":"2017","journal-title":"Cell Tissue Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.biocel.2007.08.011","article-title":"The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?","volume":"40","author":"Moeller","year":"2008","journal-title":"Int J Biochem Cell B"},{"key":"B37","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1203\/00006450-199104000-00005","article-title":"Inactivation of exogenous surfactant by pulmonary edema fluid","volume":"29","author":"Kobayashi","year":"1991","journal-title":"Pediatr Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0034-5687(94)90046-9","article-title":"Impairment of surfactant activity and ventilation by proteins in lung edema fluid","volume":"95","author":"Nitta","year":"1994","journal-title":"Respir Physiol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1529\/biophysj.105.062646","article-title":"Inhibition of pulmonary surfactant adsorption by serum and the mechanisms of reversal by hydrophilic polymers: theory","volume":"89","author":"Zasadzinski","year":"2005","journal-title":"Biophys J"},{"key":"B40","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.bbamem.2007.10.027","article-title":"A comparative study of mechanisms of surfactant inhibition","volume":"1778","author":"Gunasekara","year":"2008","journal-title":"Biochim Biophys Acta- Biomembranes"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.bpj.2012.08.024","article-title":"Exposure to polymers reverses inhibition of pulmonary surfactant by serum, meconium, or cholesterol in the captive bubble surfactometer","volume":"103","author":"Lopez-Rodriguez","year":"2012","journal-title":"Biophys J"},{"key":"B42","doi-asserted-by":"publisher","first-page":"L1260","DOI":"10.1152\/ajplung.00065.2016","article-title":"Surfactant dysfunction during overexpression of TGF-\u03b21 precedes profibrotic lung remodeling in vivo","volume":"310","author":"Lopez-Rodriguez","year":"2016","journal-title":"Am J Physio-Lung Cell Mol Physiol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.640020\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T20:59:56Z","timestamp":1613768396000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.640020\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,17]]},"references-count":42,"alternative-id":["10.3389\/fmed.2021.640020"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.640020","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,17]]},"article-number":"640020"}}